| Literature DB >> 12877747 |
Mikhail Soloviev1, Richard Barry, Elaine Scrivener, Jonathan Terrett.
Abstract
Traditional approaches to protein profiling were built around the concept of investigating one protein at a time and have long since reached their limits of throughput. Here we present a completely new approach for comprehensive compositional analysis of complex protein mixtures, capable of overcoming the deficiencies of current proteomics techniques. The Combinatorial methodology utilises the peptidomics approach, in which protein samples are proteolytically digested using one or a combination of proteases prior to any assay being carried out. The second fundamental principle is the combinatorial depletion of the crude protein digest (i.e. of the peptide pool) by chemical crosslinking through amino acid side chains. Our approach relies on the chemical reactivities of the amino acids and therefore the amino acid content of the peptides (i.e. their information content) rather than their physical properties. Combinatorial peptidomics does not use affinity reagents and relies on neither chromatography nor electrophoretic separation techniques. It is the first generic methodology applicable to protein expression profiling, that is independent of the physical properties of proteins and does not require any prior knowledge of the proteins. Alternatively, a specific combinatorial strategy may be designed to analyse a particular known protein on the basis of that protein sequence alone or, in the absence of reliable protein sequence, even the predicted amino acid translation of an EST sequence. Combinatorial peptidomics is especially suitable for use with high throughput micro- and nano-fluidic platforms capable of running multiple depletion reactions in a single disposable chip.Entities:
Year: 2003 PMID: 12877747 PMCID: PMC166277 DOI: 10.1186/1477-3155-1-4
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 10.435
Figure 1Six amino acids which contain chemically reactive side chains: Sulfhydryl groups in Cysteines (A), Guanidinyl groups in Arginines (B), Phenolic groups in Tyrosines (C), Thioether groups in Methionines (D), Imidazolyl groups in Histidines (E) and Indolyl groups of Tryptophans (F).
Figure 2Principles behind combinatorial peptidomics. Sample is proteolytically digested, but the affinity purification step of the peptidomics approach [8] is substituted by quantitative depletion of the peptide pools through chemical crosslinking of a subset of peptides (through their amino acid side chains) to a solid support (e.g. derivatised beads, derivatised capillaries, etc). Sulfhydryl groups of Cysteines, Thioether groups of Methionines, Imidazolyl groups of Histidines, Guanidinyl groups of Arginines, Phenolic groups of Tyrosines and Indolyl groups of Tryptophans can be used to covalently immobilise respective amino acids (and peptides which contain them) in a specific and fully predictable manner with respect to amino acid content. Any combination of such amino acid "filters" of various specificities or reactivities is possible (can be used sequentially or as a single "filter" with mixed specificity). Chemical depletion reduces the complexity of a peptide pool to a required degree to make it compatible with direct MS detection.
Frequently used protein cleavage reagents
| Ancrod | Arg-X, Arg-Gly | |
| Bromelain | C-terminal to Lys, Ala and Tyr | |
| Chymotrypsin | C-terminal to hydrophobic residues, e.g., Phe, Tyr, Trp. Less sensitive with Leu, Met, Ala | |
| Clostripain | C-terminal to Arg residues | 20 |
| Collagenase | N-terminal to Gly (X-Gly) in Pro-X-Gly-Pro | |
| Elastase | C-terminal to amino acids with small hydrophobic side chains | |
| Endoproteinase Arg-C | C-terminal to Arg residues | 20 |
| Endoproteinase Asp-N | N-terminal to Asp and Cys | 10 |
| Endoproteinase Glu-C | C-terminal to Asp and Glu | 10 |
| Endoproteinase Lys-C | C-terminal to Lys | 20 |
| Factor Xa | C-terminal to Arg in Gly-Arg-X | |
| Ficin | uncharged or aromatic amino acids | |
| Follipsin | Arg-X | 20 |
| Kallikrein | C-terminal to Arg in (Phe-Arg-X or Leu-Arg-X) | |
| Pepsin | Broad specificity; preference for cleavage C-terminal to Phe, Leu, and Glu | 7 |
| Thermolysin | N-terminal to amino acids with bulky hydrophobic side chains, e.g., Ile, Leu, Val, and Phe 5 | |
| Thrombin | C-terminal to Arg | |
| Trypsin | C-terminal to Lys and Arg | 10 |
| V8 protease | C-terminal to Glu, less active with Asp | |
| Cyanogen bromide | Trp, (Met) | |
| Formic acid | Asp – Pro | |
| HCl | Asp-X, X-Asp | |
| Hydroxylamine (alkaline pH) | Asn – Gly | |
| N-bromosuccinimide (NBS) or N- chlorosuccinimide | Trp | |
| 2-Nitro-5-thiocyanobenzoate (NTCB) | Cys | |
Examples of amino acid side-chain specific chemistries
| α Haloacetyl compounds: Iodoacetate; α haloacetamides; bromotrifluoroacetone; N chloroacetyliodotyramine | Cys, His, Met, Tyr | NH2 groups (slow at low pH) |
| N Maleimide derivatives: N ethylmaleimide (at pH < = 7) | Cys | NH2 groups (slow at low pH) |
| Mercurial compounds (most specific): p chloromercuribenzoate(PCMB)/p hydroxymercuribenzoate(PHMB) in H2O (optimum at pH 5, competitive displacement possible) | Cys | |
| Disulphide reagents (reversible): 5,5 dithiobis (2 nitrobenzoic acid) (DTNB); 4,4 dithiodipyridine; methyl 3 nitro 2 pyridyl disulphide; methyl 2 pyridyl disulphide | Cys | |
| N acetylimidazole | Tyr | NH2 groups (slow) |
| Diazonium compounds (optimum at pH9, unstable) | Tyr, His | NH2, Trp, Cys and Arg (slow) |
| Dicarbonyl compounds (pH > = 7): glyoxal; phenylglyoxal; 2,3 butanedione; 1,2 cyclohexanedione | Arg | Lys at pH < = 7 |
| p toluenesulphonylphenyl alaninechloromethyl ketone (TPCK); p toluenesulphonyllysine chloromethyl ketone (TLCK); Methyl-p-nitrobenzenesulphonate | His | Cys |
| Diethylpyrocarbonate (reversible at pH > = 7) | His (at pH4) | NH2 |
| 2 hydroxy 5 nitrobenzyl bromide (HNBB) | Trp | |
| p nitrophenylsulphenyl chloride | Trp, Cys | |
| α Haloacetyl compounds | Met at pH3; also Cys, His, Tyr | NH2 groups (slow at low pH) |
Synthetic peptides used in this study
| Peptide sequence* | Methionine present | m/z | Seq. ID |
| RPPQTLSR | no | 1293.56 | 1 |
| NLSPDGQYVPR | no | 1584.83 | 6 |
| SANAEDAQEFSDVER | no | 2007.13 | 9 |
| NFHQYSVEGGK | no | 1604.82 | 11 |
| LERPVR | no | 1108.38 | 16 |
| VFAQNEEIQEMAQNK | yes | 2118.43 | 4 |
| DLPLLIENMK | yes | 1524.92 | 8 |
| ETYGEMADCCAK | yes | 1659.95 | 19 |
| FIMLNLMHETTDK | yes | 1932.37 | 5 |
| DLVTQQLPHLMPSNCGLEEK | yes | 2592.07 | 13 |
* All peptides were biotinylated at their N termini.
Figure 3Depletion of peptides using Methionine-reactive amino acid filter. A – Untreated mixture containing 10 synthetic peptides (see Table 3). B – the same mixture following a Met-reactive chemistry mediated depletion (see Methods).
Figure 4Relative quantitation of peptides. A – Five peptides containing no Methionines (see Table 3) prior to (open bars) and after the depletion using Met-reactive beads (filled bars). B – Five peptides containing Methionines (see Table 3) prior to (open bars) and after the depletion using Met-reactive beads. No Met-containing peptides were detected in the depleted samples. Bar heights (both panels) represent averaged peak values detected (+/- STDEV, n = 9). Peptides are identified by their Seq IDs below each bar (on both panels).
Figure 5Differential mass labelling of the NFHQYSVEGGK peptide. A – mass spectrum of the unmodified peptide. B – mass spectrum of the same peptide modified with 4-fluorophenyl-isothiocyanate (introduced Δ m/z = 153). C – mass spectrum of the same peptide modified with 3,5-difluorophenyl-isocyanate (introduced Δ m/z = 155).
Amino acid side chain specific "filters"
| 20 | 1 | |
| 10 | 2 | |
| 7 | 3 | |
| 5 | 4 | |
| 4 | 5 | |
| 3 | 6 |
Comparison of the depletion and enrichment approaches to combinatorial peptidomics
| Decreased | Decreased | |
| Decreased (by the number of "filters" used) | Not changed (20 amino acids) | |
| A single-stage depletion is more straightforward and quantitative than a triple-stage enrichment | Enrichment approach is less straightforward and robust than the depletion | |
| Possible (larger "filters" or consecutive stages) | Possible (larger "filters" or parallel reactions) | |
| Possible (low fmol level MS sensitivity requires high pmol filter binding capacities) | Especially suitable : low fmol level MS sensitivity requires fmol binding capacities | |
| Large binding capacity of the "filters" is crucial – overloading will allow all peptides to pass the "filter" | Overloading of the "filters" is not an issue, excess of sample may be applied | |
| Products of incomplete digestion will be mostly eliminated | Products of incomplete digestion will be mostly retained and may interfere with the downstream purification and analysis steps | |
| Problematic due to limitation (see above) – excess of binding sites required to maintain efficient separation. Suitable for micro-fluidic applications | Suitable for nano-applications, since smaller number of binding sites required (compared to depletion strategy) |